Loading patent…
AssigneeJ.D. Franco & Co., LLC
InventorsEdward PARSONAGE, Stephen MICHAEL, Zachary TEGELS, Michael CALHOUN
Estimating the term…
An intravascular device including a transferable drug coating adhered to an exposed outer surface on the device, the drug coating comprising an anti-proliferative active ingredient and a xanthophyll excipient. The xanthophyll may be selected from the group consisting of lutein, astaxanthin, zeaxanthin, meso zeaxanthin, cryptotaxanthin, tunaxanthin, salmoxanthin, and parasiloxanthin, and mixtures thereof. The anti-proliferative active ingredient may be selected from the group consisting of sirolimus, everolimus, zotarolimus, bioliimus, tacrolimus, pimecrolimus, paclitaxel, and mixtures thereof. The device may be used in the treatment of eye disease.
An intravascular device including a transferable drug coating adhered to an exposed outer surface on the device, the drug coating comprising an anti-proliferative active ingredient and a xanthophyll excipient.
A method for treating a vascular stenosis comprising the steps of:
A method for treating an eye disorder using an intravascular device with an expandable portion and a transferable drug coating disposed on an outer surface of the expandable portion, wherein the drug coating comprises an anti-proliferative active ingredient and a xanthophyll excipient, the method comprising:
Dependencies are inferred from the claim text.